CMVYX | VEVYX | CMVYX / VEVYX | |
Total Expense Ratio | 0.77 | 0.66 | 117% |
Annual Report Gross Expense Ratio | 0.77 | 0.66 | 117% |
Fund Existence | 16 years | 12 years | - |
Gain YTD | -3.645 | -4.089 | 89% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.3B | 17B | 14% |
Annual Yield % from dividends | 1.21 | 1.15 | 105% |
Returns for 1 year | -4.21 | -9.20 | 46% |
Returns for 3 years | 9.84 | -2.22 | -444% |
Returns for 5 years | 62.82 | 46.07 | 136% |
Returns for 10 years | -18.76 | 40.43 | -46% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EQRR | 56.81 | 0.49 | +0.87% |
ProShares Equities for Rising Rates ETF | |||
IGE | 42.25 | 0.32 | +0.76% |
iShares North American Natural Res ETF | |||
FLRG | 33.51 | 0.07 | +0.21% |
Fidelity U.S. Multifactor ETF | |||
IYR | 93.74 | -0.41 | -0.44% |
iShares US Real Estate ETF | |||
RXL | 40.64 | -0.76 | -1.84% |
ProShares Ultra Health Care |